Profilo
Sarah Bhagat currently works at Aeovian Pharmaceuticals, Inc., as Board Member from 2019.
Dr. Bhagat also formerly worked at Inozyme Pharma, Inc., as Independent Director from 2019 to 2025, Sofinnova Investments, Inc., as General Partner from 2020 to 2022, and Atsena Therapeutics, Inc., as Chairperson.
Dr. Bhagat received her doctorate degree in 2015 from Yale University and undergraduate degree from Franklin & Marshall College.
Posizioni attive di Sarah Bhagat
| Società | Posizione | Inizio |
|---|---|---|
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Direttore/Membro del Consiglio | 01/09/2019 |
Precedenti posizioni note di Sarah Bhagat
| Società | Posizione | Fine |
|---|---|---|
| INOZYME PHARMA, INC. | Direttore/Membro del Consiglio | 01/07/2025 |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Analista di Private Equity | 01/08/2022 |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Presidente | - |
Formazione di Sarah Bhagat
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inozyme Pharma, Inc.
Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Health Technology |
















